AAAAAA
Results:
1-11
|
Results: 11
Authors:
Tauro, S
Hepburn, MD
Bowen, DT
Pippard, MJ
Citation: S. Tauro et al., Assessment of stromal function, and its potential contribution to deregulation of hematopoiesis in the myelodysplastic syndromes, HAEMATOLOG, 86(10), 2001, pp. 1038-1045
Authors:
Bowen, DT
Hellstrom-Lindberg, E
Citation: Dt. Bowen et E. Hellstrom-lindberg, Best supportive care for the anaemia of myelodysplasia: inclusion of recombinant erythropoietin therapy?, LEUK RES, 25(1), 2001, pp. 19-21
Authors:
Kottaridis, PD
Gale, RE
Frew, ME
Harrison, G
Langabeer, SE
Belton, AA
Walker, H
Wheatley, K
Bowen, DT
Burnett, AK
Goldstone, AH
Linch, DC
Citation: Pd. Kottaridis et al., The presence of a FLT3 internal tandem duplication in patients with acute myeloid leukemia (AML) adds important prognostic information to cytogeneticrisk group and response to the first cycle of chemotherapy: analysis of 854 patients from the United Kingdom Medical Research Council AML 10 and 12 trials, BLOOD, 98(6), 2001, pp. 1752-1759
Authors:
Kerr, R
Cunningham, J
Bowen, DT
Citation: R. Kerr et al., Low-dose melphalan in elderly acute myeloid leukaemia: complete remissionsbut resistant relapse with therapy-related karyotypes, LEUKEMIA, 14(5), 2000, pp. 953-953
Authors:
Wang, LH
Groves, MJ
Hepburn, MD
Bowen, DT
Citation: Lh. Wang et al., Glutathione S-transferase enzyme expression in hematopoietic cell lines implies a differential protective role for T1 and A1 isoenzymes in erythroid and for M1 in lymphoid lineages, HAEMATOLOG, 85(6), 2000, pp. 573-579
Authors:
Bowen, DT
Citation: Dt. Bowen, Oxidative stress and the myelodysplastic syndromes, LEUK RES, 24(2), 2000, pp. 139-140
Authors:
Gelly, KJ
Kerr, R
Rawlinson, S
Norris, A
Bowen, DT
Citation: Kj. Gelly et al., Transfusion-associated graft vs. host disease in a patient with high-gradeB-cell lymphoma. Should cellular products for patients with non-Hodgkin's lymphoma be irradiated?, BR J HAEM, 110(1), 2000, pp. 228-229
Authors:
West, RR
Stafford, DA
White, AD
Bowen, DT
Padua, RA
Citation: Rr. West et al., Cytogenetic abnormalities in the myelodysplastic syndromes and occupational or environmental exposure, BLOOD, 95(6), 2000, pp. 2093-2097
Authors:
Tauro, S
Bowen, DT
Citation: S. Tauro et Dt. Bowen, In vitro development of haemopoietic progenitors in myelodysplastic syndromes (MDS), LEUKEMIA, 13(3), 1999, pp. 494-495
Authors:
Gowans, ID
Hepburn, MD
Clark, DM
Patterson, G
Rawlinson, PSM
Bowen, DT
Citation: Id. Gowans et al., The role of the Sysmex SE9000 immature myeloid index and Sysmex R2000 reticulocyte parameters in optimizing the timing of peripheral blood stem cell harvesting in patients with lymphoma and myeloma, CLIN LAB H, 21(5), 1999, pp. 331-336
Authors:
Bowen, DT
Denzlinger, C
Brugger, W
Culligan, D
Gelly, K
Adlakha, S
Groves, M
Hepburn, M
Kanz, L
Citation: Dt. Bowen et al., Poor response rate to a continuous schedule of Amifostine therapy for 'low/intermediate risk' myelodysplastic patients, BR J HAEM, 103(3), 1998, pp. 785-787
Risultati:
1-11
|